Reuters logo
BRIEF-Aevi Genomic Medicine reports Q2 loss per share of $0.22
August 9, 2017 / 9:49 PM / in 4 months

BRIEF-Aevi Genomic Medicine reports Q2 loss per share of $0.22

Aug 9 (Reuters) - Aevi Genomic Medicine Inc

* Aevi Genomic Medicine reports second quarter 2017 financial results

* Q2 loss per share $0.22

* Q2 earnings per share view $-0.26 -- Thomson Reuters I/B/E/S

* ‍Company expects its reported cash balance to fund operations into Q2 of 2018​

* ‍Company had cash and cash equivalents of $21.36 million at June 30, 2017​ Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below